Literature DB >> 8945525

CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

A Mencacci1, R Spaccapelo, G Del Sero, K H Enssle, A Cassone, F Bistoni, L Romani.   

Abstract

Resistance and susceptibility to Candida albicans infection have been shown to be dependent upon the activation of CD4+ T helper (Th) type 1 or Th2 cells, respectively. To study the type, kinetics, and cytokine dependency of CD4+ Th-cell responses in low-level C. albicans infection, susceptible mice were infected with sublethal doses of C. albicans and assessed for parameters of CD4+ Th-dependent immunity. Interleukin (IL)-12 and gamma interferon were always produced early in infection regardless of the pathogen load. In contrast, production of IL-4, and hence Th2-cell reactivity, was strictly dose dependent, being induced at the higher dose of the fungus. Production of IL-12 correlated with a successful control of infection in mice exposed to the lower doses of C. albicans but not with the development of acquired immunity. An antigenic stimulus appeared to be required for IL-12 to induce a protective anticandidal response. Cytokine depletion in vivo revealed that neutralization of IL-4 was protective early but not late in infection, suggesting a different role for IL-4 in the induction versus maintenance of an ongoing anticandidal Th response. Late in infection, an exacerbative effect was also observed upon IL-12 neutralization. These results indicate that the fungal burden and timing of cytokine appearance greatly influence CD4+ Th induction and effector functions in mice with candidiasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945525      PMCID: PMC174467          DOI: 10.1128/iai.64.12.4907-4914.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Gamma interferon modifies CD4+ subset expression in murine candidiasis.

Authors:  L Romani; E Cenci; A Mencacci; R Spaccapelo; U Grohmann; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses.

Authors:  Z Grossman; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

Authors:  P A Bretscher; G Wei; J N Menon; H Bielefeldt-Ohmann
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

4.  Memory effectors: a potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen.

Authors:  L M Bradley; D D Duncan; K Yoshimoto; S L Swain
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

5.  Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent.

Authors:  C M Lezama-Davila; D M Williams; G Gallagher; J Alexander
Journal:  Parasite Immunol       Date:  1992-01       Impact factor: 2.280

6.  Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

Authors:  J M Carballido; N Carballido-Perrig; G Terres; C H Heusser; K Blaser
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

7.  Course of primary candidiasis in T cell-depleted mice infected with attenuated variant cells.

Authors:  L Romani; A Mencacci; E Cenci; P Mosci; G Vitellozzi; U Grohmann; P Puccetti; F Bistoni
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

8.  CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; P Mosci; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen.

Authors:  H J Burstein; A K Abbas
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  19 in total

1.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

Authors:  C A Power; G Wei; P A Bretscher
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.

Authors:  Ashraf S Ibrahim; Brad J Spellberg; Valentina Avenissian; Yue Fu; Scott G Filler; John E Edwards
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.

Authors:  Donatella Pietrella; Rosanna Mazzolla; Patrizia Lupo; Lucia Pitzurra; Maria Jesus Gomez; Robert Cherniak; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans.

Authors:  R La Valle; S Sandini; M J Gomez; F Mondello; G Romagnoli; R Nisini; A Cassone
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.

Authors:  Brad Spellberg; Douglas Johnston; Quynh Trang Phan; John E Edwards; Samuel W French; Ashraf S Ibrahim; Scott G Filler
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern.

Authors:  Celina Arruda; Rita C Valente-Ferreira; Adriana Pina; Suely S Kashino; Raquel A Fazioli; Celidéia A C Vaz; Marcello F Franco; Alexandre C Keller; Vera L G Calich
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.